![Chris Storgard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Storgard
Chief Tech/Sci/R&D Officer at
DESIGN THERAPEUTICS, INC.
Net worth: - $ as of 30/05/2026
Profile
Chris M.
Storgard is currently Chief Medical Officer at Design Therapeutics, Inc. since 2025.
Formerly, Dr. Storgard was Chief Medical Officer at Heron Therapeutics, Inc. from 2019 to 2024, Chief Medical Officer at Fate Therapeutics, Inc. from 2016 to 2018, Vice President-Clinical Research & Development at Ardea Biosciences, Inc. from 2013 to 2016, Member & Assistant Professor at Mayo Medical School from 2001 to 2004, and Chief Medical Officer at ADARx Pharmaceuticals, Inc. Dr. Storgard earned a doctorate from the University of Saskatchewan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Chris Storgard active positions
| Companies | Position | Start |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 16/04/2025 |
Former positions of Chris Storgard
| Companies | Position | End |
|---|---|---|
| HERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 29/02/2024 |
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 04/11/2018 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Chief Tech/Sci/R&D Officer | 01/01/2016 |
Mayo Medical School
 Mayo Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2004 |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Chief Tech/Sci/R&D Officer | - |
Training of Chris Storgard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Mayo Medical School
Mayo Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
- Stock Market
- Insiders
- Chris Storgard
